Zacks Research Boosts Earnings Estimates for Kimberly-Clark

Kimberly-Clark Co. (NYSE:KMB) – Zacks Research boosted their FY2024 earnings per share (EPS) estimates for Kimberly-Clark in a report released on Tuesday, November 12th. Zacks Research analyst R. Department now forecasts that the company will earn $7.27 per share for the year, up from their previous forecast of $7.21. The consensus estimate for Kimberly-Clark’s current full-year earnings is $7.26 per share. Zacks Research also issued estimates for Kimberly-Clark’s Q4 2024 earnings at $1.47 EPS, Q1 2025 earnings at $1.97 EPS, Q2 2025 earnings at $1.87 EPS, Q3 2025 earnings at $1.86 EPS, Q4 2025 earnings at $1.82 EPS, FY2025 earnings at $7.52 EPS, Q1 2026 earnings at $2.09 EPS, Q2 2026 earnings at $1.97 EPS, Q3 2026 earnings at $1.95 EPS and FY2026 earnings at $7.75 EPS.

Kimberly-Clark (NYSE:KMB) last announced its quarterly earnings data on Tuesday, October 22nd. The company reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.69 by $0.14. The company had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $5.06 billion. Kimberly-Clark had a net margin of 12.97% and a return on equity of 198.59%. Kimberly-Clark’s quarterly revenue was down 3.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.74 EPS.

KMB has been the subject of a number of other reports. StockNews.com downgraded Kimberly-Clark from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 30th. UBS Group cut their price objective on Kimberly-Clark from $153.00 to $151.00 and set a “neutral” rating for the company in a research report on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Kimberly-Clark from $146.00 to $147.00 and gave the stock a “hold” rating in a research report on Tuesday, October 8th. JPMorgan Chase & Co. cut their price target on shares of Kimberly-Clark from $142.00 to $140.00 and set an “underweight” rating for the company in a report on Wednesday, October 23rd. Finally, TD Cowen started coverage on shares of Kimberly-Clark in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $161.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Kimberly-Clark has a consensus rating of “Hold” and a consensus target price of $149.93.

Kimberly-Clark Trading Down 0.4 %

NYSE KMB opened at $131.68 on Thursday. The company has a quick ratio of 0.55, a current ratio of 0.83 and a debt-to-equity ratio of 4.77. The stock has a market capitalization of $43.91 billion, a P/E ratio of 17.15, a P/E/G ratio of 2.78 and a beta of 0.40. Kimberly-Clark has a 52-week low of $117.67 and a 52-week high of $149.30. The firm has a 50-day moving average price of $140.08 and a 200 day moving average price of $139.18.

Kimberly-Clark Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 3rd. Shareholders of record on Friday, December 6th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.71%. The ex-dividend date of this dividend is Friday, December 6th. Kimberly-Clark’s dividend payout ratio (DPR) is presently 63.29%.

Institutional Trading of Kimberly-Clark

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. grew its stake in Kimberly-Clark by 3.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,060,744 shares of the company’s stock worth $1,431,443,000 after acquiring an additional 358,926 shares during the period. Price T Rowe Associates Inc. MD grew its position in Kimberly-Clark by 19.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock valued at $762,279,000 after acquiring an additional 944,920 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Kimberly-Clark by 0.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,712,258 shares of the company’s stock worth $385,900,000 after acquiring an additional 20,953 shares during the last quarter. Capital World Investors raised its holdings in shares of Kimberly-Clark by 17.8% in the 1st quarter. Capital World Investors now owns 2,269,492 shares of the company’s stock worth $293,559,000 after purchasing an additional 342,790 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Kimberly-Clark by 22.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,934,655 shares of the company’s stock valued at $267,383,000 after purchasing an additional 354,501 shares in the last quarter. Hedge funds and other institutional investors own 76.29% of the company’s stock.

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.